SERTAD1 and cancer: Suppressing SERTAD1 slightly increased mitochondrial activity in cancer cells (Figure 4A,B), but the phenomenon was clearly observed in mouse embryonic fibroblasts (MEFs) from KO-SERTAD1 mice compared with wild-type controls (Figure 4C,D, Supplementary Figure S2A).